News Briefs: Boston Sci Settlement; C.R. Bard Scores Patent Victory
This article was originally published in The Gray Sheet
Boston Scientific owes another $30 million to settle more charges related to Guidant ICD issues. C.R. Bard closer to receiving big payout from Gore on patent case. FDA issues a safety alert on St. Jude’s Amplatzer occluder More news briefs.